Immune responses to hemophilia A treatment have long been a mystery, but now they are being unraveled.

Published Date: 16 Aug 2023

Patients with the genetic disease hemophilia A undergo factor VIII protein replacement therapy to restore the blood's supply of this clotting protein, thereby reducing the risk of life-threatening bleeding. 30 percent of these patients, regrettably.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

More Americans Are Surviving Cancer. But the Mental Health Challenges Can Persist.

2.

Glioma Outcomes Shaped by Subtype More Than Tx Sequence

3.

We Don't Always Know What's 'Best' for Our Patients

4.

Should the UK introduce targeted prostate cancer screening? The case for and against

5.

Germline Profiling May Improve Risk Stratification in t-MNs


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot